SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-084277
Filing Date
2022-03-25
Accepted
2022-03-24 21:56:05
Documents
15
Period of Report
2022-03-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d340860d8k.htm   iXBRL 8-K 25444
2 EX-99.1 d340860dex991.htm EX-99.1 25114
6 GRAPHIC g340860g18g92.jpg GRAPHIC 10746
7 GRAPHIC g340860g62f83.jpg GRAPHIC 5425
  Complete submission text file 0001193125-22-084277.txt   203876

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA meip-20220324.xsd EX-101.SCH 2863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20220324_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20220324_pre.xml EX-101.PRE 11266
9 EXTRACTED XBRL INSTANCE DOCUMENT d340860d8k_htm.xml XML 3342
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 22768112
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences